ALINT Share Price Performance
€0.16
-0.34 (-68.19%)
Price €0.16
Share Price€0.16
IntegraGen SA (EPA:ALINT) Looks Inexpensive After Falling 41% But Perhaps Not Attractive Enough
Oct 03
IntegraGen SA Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 0 Fair Values set on narratives written by author
ALINT Community Narratives
There are no narratives available yet.
IntegraGen SA Key Details
Last Reported Earnings
Dec 31, 2024
Next Reporting Earnings
n/a
- Earnings per share (EPS)
- -0.039
- Gross Margin
- 21.19%
- Net Profit Margin
- -2.94%
- Debt/Equity Ratio
- 36.6%
IntegraGen SA Competitors
Snowflake Analysis
About ALINT
- Founded
- 2000
- Employees
- 40
- CEO
- WebsiteView website
IntegraGen SA provides researchers with sequencing solutions, data management tools, and biostatistical, and bioinformatics support services in France. The company’s genomic pharma services DNA sequencing for oncology and rare disease research; and NGS testing for cancer research. It also provides MERCURY, an online biological interpretation tool for oncology intended to assist pathologists and oncologists in transforming raw data obtained through high-throughput sequencing into a molecular report for translational and clinical research use; Galileo, a cloud-based app for dynamic exporation of RNA-Seq expression data; and GeCo, a genomic consulting service that offers researchers with access to biostatistics and bioanalytics experts. IntegraGen SA was incorporated in 2000 and is headquartered in Évry, France. IntegraGen SA operates as a subsidiary of OncoDNA SA.
Market Insight
Q4 2025 is off to a flying start with record highs being printed left, right, and center. US and Japanese stocks made fresh new highs, while the gold price powered through $4,000 for the first time, and Bitcoin crossed the $126k level. Is this all a case of USD weakness, irrational exuberance, or solid fundamentals? This week, we are reviewing Q3 market performance, Q2 earnings season, and the outlook heading into the end of 2025…
Continue reading
French Market Performance
- 7 Days: -2.2%
- 3 Months: 0.3%
- 1 Year: 2.8%
- Year to Date: 5.1%
Over the last 7 days, the market has remained flat, with no particular sector making any big moves this week. Meanwhile, the market is actually up 5.0% over the past year. As for the next few years, earnings are expected to grow by 12% per annum. Market details ›